US$ 29.27
glp 1 drugs for alcohol use disorder Ozempic and Other GLP-1 Alcoholism: Do They Work? A new clinical trial supported
Description
It randomised 156 participants with early disease to daily subcutaneous lixisenatide or placebo for 12 months, followed by a 2-month washout
Tang B, Sjlander A, Wastesson J, Maura G, Blotiere PO, Szilcz M, et al

Muscle isnt just for athletesits essential to health and longevity

Additionally, it is one of three drugs approved to treat obesity in adolescents 12 years and older, with Qsymia and Wegovy being the other two

Most agents undergo proteolytic degradation and renal elimination

Obesity and cardiovascular disease: an ESC clinical consensus statement
